Welcome to our dedicated page for MFA Fincl SEC filings (Ticker: MFAO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MFA Fincl's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MFA Fincl's regulatory disclosures and financial reporting.
MFA Financial President and Chief Investment Officer Bryan Wulfsohn reported multiple equity award transactions dated January 8, 2026. He acquired 67,914 shares of common stock from the settlement of time-based restricted stock units and 232,090 shares tied to performance-based restricted stock units, all at an exercise price of $0 per share as they are phantom share awards.
The filing shows share surrenders of 35,432 and 13,339 common shares at $9.57 per share to satisfy tax obligations arising from these settlements. The performance-based units were granted in January 2023, vesting based on total stockholder return over the three years ended December 31, 2025, with vested PRSUs and related dividend-equivalent units scheduled to settle in common stock in January 2027. The number of shares beneficially owned was also reduced to reflect liquidation of 819 shares previously held in the company’s 401(k) plan after MFA stock was removed as an investment option.
MFA Financial, Inc. senior vice president and co-controller Natasha Seemungal reported multiple equity award transactions on common stock and phantom share units. On January 8, 2026, time-based restricted stock units converted into 4,922 shares of common stock, and performance-based restricted stock units tied to three-year total shareholder return contributed an additional 16,823 shares, increasing her directly held common stock to 33,826 shares before tax withholding.
To cover tax obligations from these settlements, she surrendered 2,266 shares and 1,470 shares of common stock at a price of $9.57 per share, leaving 30,090 shares of common stock held directly. Corresponding phantom share awards in the form of TRSUs and PRSUs were reduced by 4,922 and 9,434 phantom shares, with vested PRSUs, including dividend-equivalent units, scheduled to settle in common stock in January 2027.
MFA Financial, Inc. insider Harold E. Schwartz, a Senior Vice President, reported equity compensation activity on January 8, 2026. He acquired 26,575 shares of common stock from the settlement of time-based restricted stock units (TRSUs) and an additional 90,821 shares of common stock tied to performance-based restricted stock units (PRSUs), both economically equivalent to common shares.
To cover tax obligations from these settlements, Schwartz surrendered 15,465 shares and 5,582 shares of common stock at a price of $9.57 per share. Following these transactions, he beneficially owned 159,518 shares of MFA common stock. The PRSUs, including 28,420 units from dividend equivalents, are scheduled to settle in January 2027 as one share of common stock for each vested phantom share, based on MFA’s total stockholder return over the three years ended December 31, 2025.
MFA Financial, Inc. executive Lori R. Samuels, SVP & Chief Loan Operations Officer, reported equity award activity involving company stock and phantom shares. On January 8, 2026, 15,749 time-based restricted stock units (TRSUs) settled into the same number of common shares, and performance-based RSUs (PRSUs) granted in January 2023 vested, representing 53,827 common shares, including 16,848 units tied to dividend equivalents. The vested PRSUs are scheduled to settle in January 2027, with each phantom share converting into one common share. To cover tax obligations from these settlements, 9,479 and 3,461 common shares were surrendered at a price of $9.57 per share. Following these transactions, Samuels continues to hold common stock and phantom share balances as reflected in the tables.
MFA Financial senior vice president and chief financial officer Michael C. Roper reported multiple equity award settlements and related tax share surrenders on January 8, 2026. Time-based restricted stock units (TRSUs), structured as phantom shares granted in January 2023, settled into 15,749 shares of common stock at $0 per share. Performance-based restricted stock units (PRSUs) granted at the same time vested into 53,827 shares, including additional PRSUs credited for dividend equivalents over the three-year performance period ended December 31, 2025.
To cover tax obligations from these settlements, Roper surrendered 8,810 shares and 3,217 shares of common stock at $9.57 per share. Following the reported transactions, he held 88,138 shares of MFA common stock directly, along with substantial remaining phantom share balances. A prior change to MFA’s 401(k) plan eliminated MFA stock as an investment option, reducing his beneficial ownership by 1,000 shares previously held in that plan.
MFA Financial, Inc. senior vice president and co-controller Mei Lin reported the vesting and settlement of stock-based awards granted in January 2023. On January 8, 2026, 4,922 time-based restricted stock units and 16,823 performance-based restricted stock units, structured as phantom shares, were converted into common stock at an exercise price of $0 per share. Phantom shares are described as economically equivalent to one share of MFA common stock and settle share-for-share.
To cover tax obligations from these settlements, Lin surrendered 2,057 and 1,335 common shares at a price of $9.57 per share. Following these transactions, Lin directly held 32,131 common shares. In the derivative holdings, 4,922 and 9,434 phantom shares were settled, leaving 51,968 and 42,534 phantom shares outstanding in two award lines. The performance-based awards vested based on MFA’s total stockholder return for the three years ended December 31, 2025, and vested PRSUs, including 5,268 units from dividend equivalents, are scheduled to settle in common stock in January 2027.
MFA Financial CEO Craig L. Knutson, who also serves as a director, reported several equity award-related transactions dated January 8, 2026. He acquired 157,481 shares of common stock upon settlement of time-based restricted stock units granted in January 2023 and 538,186 shares of common stock tied to performance-based restricted stock units from the same grant.
Phantom shares used in these awards are each the economic equivalent of one share of MFA common stock and settle one-for-one in stock. The filing shows share dispositions of 81,087 shares and 42,127 shares at $9.57 per share, representing shares surrendered to cover tax obligations on the equity settlements. The company also previously eliminated MFA common stock as an investment option in its 401(k) plan, reducing Knutson’s reported beneficial ownership by 14,710 shares. Certain vested performance-based units, including dividend-equivalent units, are scheduled to settle in stock in January 2027.
MFA Financial, Inc. reported an equity award to a senior executive in a Form 4 filing. On 01/02/2026, an officer serving as Sr VP & Chief Accounting Officer received two types of phantom share awards tied to MFA common stock.
The officer was granted 8,815 phantom shares that are scheduled to vest, subject to forfeiture, on December 31, 2028 and then be settled in the same number of MFA common shares within 30 days after vesting. Each phantom share represents the right to receive one share of common stock.
The filing also reports 13,649 performance-based phantom shares, described as a target award. The actual shares earned can range from 0% to 200% of this target, based on MFA’s absolute total stockholder return and its total stockholder return versus a designated peer group over a three-year period ending around the vesting date. These performance-based phantom shares are expected to vest generally on December 31, 2028, with settlement in MFA common stock in January 2030, adjusted for the value of dividends during the vesting period.
MFA Financial, Inc. reported an equity award for its Chief Executive Officer and director on a Form 4 dated 01/02/2026. The filing shows grants of phantom shares, which each represent the right to receive one share of MFA common stock.
The CEO received 176,916 time-based phantom shares that are scheduled to vest on December 31, 2028, subject to forfeiture, and to be settled in an equivalent number of MFA common shares within 30 days after vesting. In addition, the CEO received 273,938 performance-based phantom shares, representing a target amount. The actual number of shares earned can range from 0% to 200% of this target, based on MFA’s absolute total stockholder return and its return relative to a designated peer group over a three-year period.
The performance-based phantom shares are generally expected to vest on December 31, 2028, after certification of performance, with settlement in MFA common stock in January 2030, adjusted for the value of dividends paid during the vesting period on the shares that ultimately vest.
MFA Financial reported an equity compensation grant to a senior executive. On 01/02/2026, a Sr. VP & Co-Controller received two awards of phantom shares, each representing the right to receive one share of MFA common stock.
The first award covers 6,296 phantom shares that are scheduled to vest, subject to forfeiture, on December 31, 2028 and then be settled in the same number of MFA shares within 30 days after vesting. The second is a performance-based grant with a target of 9,750 phantom shares at a price of $0.
For the performance award, the actual number of MFA shares ultimately delivered can range from 0% to 200% of the target, based on MFA’s absolute total stockholder return and its total stockholder return versus a designated peer group over a three-year period. These performance-based phantom shares are expected to vest generally on December 31, 2028, with settlement in MFA common stock in January 2030, adjusted for dividends paid during the vesting period.